RFK Jr. widens peptide access
The gist
HHS Secretary Robert F. Kennedy Jr. said he would allow broad patient access to six unapproved peptide injections.
Most lack strict testing, and FDA staff scientists had opposed the move.
How it unfolded
- Jul 23, 2026The FDA's Pharmacy Compounding Advisory Committee considered seven experimental peptides; FDA staff recommended against adding any, citing safety concerns, but the committee recommended adding six. The votes were recommendations and did not change the rules.
- Oct 20, 2026Kennedy said on Fox News' "The Will Cain Show" that "Americans are going to be buying these anyway," describing a goal of a regulated marketplace with inspected factories.
- Oct 22, 2026The White House was reviewing a proposal to broaden peptide access that included more patient protections than initially expected, according to people familiar with the matter.